PL345574A1 - Angiogenesis inhibitors - Google Patents
Angiogenesis inhibitorsInfo
- Publication number
- PL345574A1 PL345574A1 PL99345574A PL34557499A PL345574A1 PL 345574 A1 PL345574 A1 PL 345574A1 PL 99345574 A PL99345574 A PL 99345574A PL 34557499 A PL34557499 A PL 34557499A PL 345574 A1 PL345574 A1 PL 345574A1
- Authority
- PL
- Poland
- Prior art keywords
- angiogenesis inhibitors
- angiogenesis
- inhibitors
- Prior art date
Links
- 229940121369 angiogenesis inhibitor Drugs 0.000 title 1
- 239000004037 angiogenesis inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/04—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11088598A | 1998-07-06 | 1998-07-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL345574A1 true PL345574A1 (en) | 2001-12-17 |
Family
ID=22335452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL99345574A PL345574A1 (en) | 1998-07-06 | 1999-07-06 | Angiogenesis inhibitors |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1094812A4 (en) |
| JP (1) | JP2002519377A (en) |
| KR (1) | KR20010079497A (en) |
| CN (1) | CN1308534A (en) |
| AU (1) | AU4862599A (en) |
| BR (1) | BR9911885A (en) |
| CA (1) | CA2336774A1 (en) |
| HU (1) | HUP0104509A3 (en) |
| ID (1) | ID28125A (en) |
| NO (1) | NO20010085L (en) |
| PL (1) | PL345574A1 (en) |
| SK (1) | SK242001A3 (en) |
| WO (1) | WO2000001383A1 (en) |
| ZA (1) | ZA200007405B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9805655D0 (en) | 1998-03-16 | 1998-05-13 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
| DE60130910T2 (en) | 2000-04-17 | 2008-07-10 | Ucb Pharma, S.A. | ENAMINE DERIVATIVES AS CELL ADHESION MOLECULES |
| US6486174B2 (en) | 2000-08-07 | 2002-11-26 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
| EP1488455B1 (en) | 2002-03-20 | 2010-08-11 | Koninklijke Philips Electronics N.V. | Active matrix electroluminescent display devices and their manufacture |
| ES2436170T3 (en) * | 2003-12-03 | 2013-12-27 | The Scripps Research Institute | Antibodies and peptides specific for integrin alfa II beta3 |
| CN108430488B (en) * | 2015-11-26 | 2021-03-12 | 大和药品株式会社 | Angiogenesis inhibitors |
| CN109535035A (en) * | 2019-01-08 | 2019-03-29 | 吉尔生化(上海)有限公司 | A kind of preparation method of the N- benzyloxycarbonyl group -3- amino-alanine tert-butyl ester |
| CN113773260B (en) * | 2021-08-26 | 2023-09-22 | 华南师范大学 | A kind of covalent organic material and its preparation method and application |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE188379T1 (en) * | 1992-10-14 | 2000-01-15 | Merck & Co Inc | FIBRINOGEN RECEPTOR ANTAGONISTS |
| JPH08504194A (en) * | 1992-12-01 | 1996-05-07 | メルク エンド カンパニー インコーポレーテッド | Fibrinogen receptor antagonist |
| JPH10501222A (en) * | 1994-05-27 | 1998-02-03 | メルク エンド カンパニー インコーポレーテッド | Compounds for inhibiting osteoclast-mediated bone resorption |
| JP2000508319A (en) * | 1996-04-10 | 2000-07-04 | メルク エンド カンパニー インコーポレーテッド | αvβ3 antagonist |
-
1999
- 1999-07-06 PL PL99345574A patent/PL345574A1/en not_active Application Discontinuation
- 1999-07-06 JP JP2000557829A patent/JP2002519377A/en active Pending
- 1999-07-06 KR KR1020017000144A patent/KR20010079497A/en not_active Withdrawn
- 1999-07-06 ID IDW20010172A patent/ID28125A/en unknown
- 1999-07-06 HU HU0104509A patent/HUP0104509A3/en unknown
- 1999-07-06 EP EP99932289A patent/EP1094812A4/en not_active Withdrawn
- 1999-07-06 BR BR9911885-8A patent/BR9911885A/en not_active Application Discontinuation
- 1999-07-06 SK SK24-2001A patent/SK242001A3/en unknown
- 1999-07-06 WO PCT/US1999/015252 patent/WO2000001383A1/en not_active Ceased
- 1999-07-06 CA CA002336774A patent/CA2336774A1/en not_active Abandoned
- 1999-07-06 CN CN99808280A patent/CN1308534A/en active Pending
- 1999-07-06 AU AU48625/99A patent/AU4862599A/en not_active Abandoned
-
2000
- 2000-12-12 ZA ZA200007405A patent/ZA200007405B/en unknown
-
2001
- 2001-01-05 NO NO20010085A patent/NO20010085L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010079497A (en) | 2001-08-22 |
| ZA200007405B (en) | 2001-09-21 |
| HUP0104509A2 (en) | 2002-04-29 |
| CN1308534A (en) | 2001-08-15 |
| BR9911885A (en) | 2001-03-27 |
| ID28125A (en) | 2001-05-03 |
| EP1094812A4 (en) | 2003-04-16 |
| EP1094812A1 (en) | 2001-05-02 |
| JP2002519377A (en) | 2002-07-02 |
| NO20010085L (en) | 2001-03-05 |
| SK242001A3 (en) | 2001-10-08 |
| NO20010085D0 (en) | 2001-01-05 |
| CA2336774A1 (en) | 2000-01-13 |
| WO2000001383A1 (en) | 2000-01-13 |
| AU4862599A (en) | 2000-01-24 |
| HUP0104509A3 (en) | 2002-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1097147A4 (en) | Novel angiogenesis inhibitors | |
| GB9900416D0 (en) | Inhibitors | |
| ZA98376B (en) | Sulfamide-metalloprotease inhibitors | |
| GB9807692D0 (en) | Optival devices | |
| GB2321641B (en) | Sulfamide-metalloprotease inhibitors | |
| HUP0202076A3 (en) | Triazine angiogenesis inhibitors | |
| GB9812309D0 (en) | Fluid-treatment devices | |
| PL345574A1 (en) | Angiogenesis inhibitors | |
| GB9821993D0 (en) | Centraliser | |
| EP1153022A4 (en) | Prothease inhibitors | |
| GB9816729D0 (en) | Substituted cyclohexylaminopyrimidines | |
| PL347397A1 (en) | Substituted 3-aryl-pyrazoles | |
| GB2389113B (en) | B-secretase inhibitor | |
| HUP0103576A3 (en) | Kdel receptor inhibitors | |
| PL345866A1 (en) | Substituted cyclooctadepsipeptides | |
| GB9800681D0 (en) | Novel angiogenesis inhibitors | |
| GB9810544D0 (en) | Novel angiogenesis inhibitors | |
| GB9822700D0 (en) | Novel angiogenesis inhibitors | |
| GB2338195B (en) | Fluid - treatment devices | |
| GB9803416D0 (en) | Inhibitors | |
| GB9828697D0 (en) | Inhibitors | |
| GB9826992D0 (en) | Inhibitors | |
| GB9917294D0 (en) | Inhibitors | |
| GB9929340D0 (en) | Inhibitors | |
| GB9929341D0 (en) | Inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |